scholarly journals Implantable Cardioverter Defibrillator mHealth App for Physician Referrals and eHealth Education: ICD-TEACH Pilot Study

JMIR Cardio ◽  
10.2196/10499 ◽  
2018 ◽  
Vol 2 (2) ◽  
pp. e10499
Author(s):  
Sumeet Gandhi ◽  
Carlos A Morillo ◽  
Jon-David Schwalm
2018 ◽  
Author(s):  
Sumeet Gandhi ◽  
Carlos A Morillo ◽  
Jon-David Schwalm

BACKGROUND Mobile health (mHealth) decision tools for implantable cardioverter defibrillator may increase physician knowledge and overall patient care. OBJECTIVE The goals of the ICD-TEACH pilot study were to design a smartphone app or mHealth technology with a novel physician decision support algorithm, implement a direct referral mechanism for device implantation from the app, and assess its overall usability and feasibility with physicians involved in the care of patients with an implantable cardioverter defibrillator. METHODS The initial design and development of the mHealth or smartphone app included strategic collaboration from an information technology company and key stakeholders including arrhythmia specialists (electrophysiologists), general cardiologists, and key members of the hospital administrative team. A convenience sampling method was used to recruit general internists or cardiologists that refer to our local tertiary care center. Physicians were asked to incorporate the mHealth app in daily clinical practice and avail the decision support algorithm and direct referral feature to the arrhythmia clinic. Feasibility assessment, in the form of a physician survey, was conducted after initial mHealth app use (within 3 months) addressing the physicians’ overall satisfaction with the app, compliance, and reason for noncompliance; usability assessment of the mHealth app was addressed in the physician survey for technical or hardware problems encountered while using the app and suggestions on improvement. RESULTS A total of 17 physicians agreed to participate in the pilot study with 100% poststudy survey response rate. Physicians worked in an academic practice, which included both inpatient and ambulatory care. System Usability Scale was applied with an average score of 77 including the 17 participants (>68 points is above average). Regarding the novel physician decision support algorithm for implantable cardioverter defibrillator referral, 11% (1/9) strongly agreed and 78% (7/9) agreed that the algorithm for device eligibility was easy to use. Only 1 patient was referred through the direct referral system via the mHealth app during the pilot study of 3 months. Feasibility assessment showed that 46% (5/11) strongly agreed and 55% (6/11) agreed that the mHealth app would be utilized if integrated into an electronic medical record (EMR) where data are automatically sent to the referring arrhythmia clinic. CONCLUSIONS The ICD-TEACH pilot study revealed high usability features of a physician decision support algorithm; however, we received only 1 direct referral through our app despite supportive feedback. A specific reason from our physician survey included the lack of integration into an EMR. Future studies should continue to systematically evaluate smartphone apps in cardiology to assess usability, feasibility, and strategies to integrate into daily workflow.


Heart Rhythm ◽  
2021 ◽  
Author(s):  
Giovanni B. Forleo ◽  
Alessio Gasperetti ◽  
Alexander Breitenstein ◽  
Mikael Laredo ◽  
Marco Schiavone ◽  
...  

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S305
Author(s):  
David O’Donnell ◽  
Haris M. Haqqani ◽  
Emily Kotschet ◽  
David Shaw ◽  
Anil Prabhu ◽  
...  

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
E Kotschet ◽  
I Crozier ◽  
H Haqqani ◽  
J Alison ◽  
A Thompson ◽  
...  

Abstract Background The investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) is an implantable defibrillator with defibrillation and pacing therapies, including the potential for antitachycardia pacing (ATP). Purpose To characterize chronic EV ICD system performance through 12 months of follow-up. Methods The first-in-human EV ICD Pilot study was prospectively conducted at four centers in Australia and New Zealand. Patients with Class I or IIa indications for ICD were enrolled between July and December of 2018. A defibrillation lead was inserted into the substernal space under radiologic guidance and a device was positioned close to the left midaxillary line. Figure 1 illustrates the implanted EV ICD. Defibrillation testing was conducted at implant and chronically in 5 patients. Follow-ups were conducted at pre-hospital discharge, 2 weeks, 4–6 weeks and 3 months post-implant, and every 6 months thereafter. Results A total of 26 patients were enrolled and 21 underwent the EV ICD implant procedure with no intraprocedural complications. Median energy for defibrillation at implant was 15 J; mean R-wave amplitude was 3.4±2.0 mV; mean pacing capture threshold was 5.1±2.0 volts. Seventeen of 21 implanted patients entered into chronic follow-up after successful system placement and implant testing, and 14 patients continue to be followed, representing >180 patient-months of total follow-up. Multiple episodes of spontaneous ventricular tachycardia (VT) were detected in one patient and either self-terminated or successfully cardioverted following unsuccessful ATP. One patient received an inappropriate shock secondary to lead tip displacement with subsequent P-wave oversensing. Elective chronic defibrillation testing was performed at physician discretion and converted 5 of 5 patients with ≤40 J (maximum energy of device). Three patients had the system electively removed due to 1) inappropriate shock after lead displacement, 2) recurrent VT without ATP termination, and 3) inadequate chronic safety margin for defibrillation. Conclusions The EV ICD is a novel platform for delivering high voltage therapy. Chronic system performance has generally remained stable during 12 months of follow-up and the device has demonstrated the ability to detect and treat VT. Fluoro images of implanted system Funding Acknowledgement Type of funding source: Private company. Main funding source(s): Medtronic plc


Sign in / Sign up

Export Citation Format

Share Document